Incidence of Human Leukocyte Antigen Class I Antibodies and Impact on Platelet Engraftment, Transfusions, and Bleeding in Recipients of Gene Therapy for Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia.

Frangoul H, McManus M, Carroll C, Fossey S, Rowe M, Roelandts A, McCartney E, Aide S, Stults A, Forbes S, Riggins C, Morgan K, Tilman R, Duckworth M, Davis N, Bruce K, Battiwala M, Domm J, Evans M

Open source

DOI: 10.1016/j.jtct.2026.08.027
Published: 2026 Aug 15
Container: Transplantation and cellular therapy
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.jtct.2026.08.027,
  title = {Incidence of Human Leukocyte Antigen Class I Antibodies and Impact on Platelet Engraftment, Transfusions, and Bleeding in Recipients of Gene Therapy for Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia.},
  author = {Frangoul H and McManus M and Carroll C and Fossey S and Rowe M and Roelandts A and McCartney E and Aide S and Stults A and Forbes S and Riggins C and Morgan K and Tilman R and Duckworth M and Davis N and Bruce K and Battiwala M and Domm J and Evans M},
  year = {2026},
  journal = {Transplantation and cellular therapy},
  doi = {10.1016/j.jtct.2026.08.027},
  url = {https://doi.org/10.1016/j.jtct.2026.08.027}
}

RIS

TY  - JOUR
TI  - Incidence of Human Leukocyte Antigen Class I Antibodies and Impact on Platelet Engraftment, Transfusions, and Bleeding in Recipients of Gene Therapy for Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia.
AU  - Frangoul H
AU  - McManus M
AU  - Carroll C
AU  - Fossey S
AU  - Rowe M
AU  - Roelandts A
AU  - McCartney E
AU  - Aide S
AU  - Stults A
AU  - Forbes S
AU  - Riggins C
AU  - Morgan K
AU  - Tilman R
AU  - Duckworth M
AU  - Davis N
AU  - Bruce K
AU  - Battiwala M
AU  - Domm J
AU  - Evans M
PY  - 2026
JO  - Transplantation and cellular therapy
DO  - 10.1016/j.jtct.2026.08.027
UR  - https://doi.org/10.1016/j.jtct.2026.08.027
ER  -

APA

H, F., M, M., C, C., S, F., M, R., A, R., E, M., S, A., A, S., S, F., C, R., K, M., R, T., M, D., N, D., K, B., M, B., J, D., & M, E. (2026). Incidence of Human Leukocyte Antigen Class I Antibodies and Impact on Platelet Engraftment, Transfusions, and Bleeding in Recipients of Gene Therapy for Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia.. Transplantation and cellular therapy. https://doi.org/10.1016/j.jtct.2026.08.027

Source records

pubmed · retrieved 2026-09-26T22:58:15.796Z